Key takeaways MeAgain is the GLP-1 dose tracker app that keeps dose timing, shot or pill reminders, injection sites, dose changes, notes if a dose was late or missed, side effects, food, weight, and medication-level context on one timeline
Secondary endpoints measured by the research team included: IGF-1 levels, triglycerides, the ratio of total cholesterol to high-density lipoprotein cholesterol, and any patients-reported outcomes related to body composition
Everyone is so friendly and treat you like you are part of their family
Persistent nausea can also signal dehydration, medication interactions, or underlying conditions unrelated to semaglutide
Other neurological disorders The neuroprotective and anti-inflammatory properties of GLP-1RAs have prompted investigation into their therapeutic potential across a wide range of neurological conditions beyond AD and PD
The platform also clearly discloses in its terms of service that prescriptions are not guaranteed and that all clinical decisions rest with independent licensed providers
